Core Viewpoint - China Life Insurance (02628.HK) is currently in a steady upward channel, with short-term support levels at HKD 15.50 and HKD 14.60, and resistance levels set at HKD 16.60 and HKD 17.00. The overall upward probability is 52%, indicating conditions for continued upward movement [1]. Technical Analysis - The stock price has stabilized above all major moving averages, including the 10-day moving average at HKD 15.80, the 30-day moving average at HKD 14.92, and the 60-day moving average at HKD 15.10, forming a bullish structure [1]. - The trading volume reached HKD 621 million, providing substantial financial support for the stock's rise and reflecting increased market participation [1]. - The RSI index is currently at 68, indicating strong bullish sentiment, while the Williams and Stochastic indicators are in the overbought zone but have not shown clear signs of weakening [1]. - The CCI and psychological line indicators are also leaning bullish, with momentum and volatility indicators supporting the current upward trend [1]. - The Bollinger Bands show the stock is approaching the upper band, with MACD and Ichimoku indicators simultaneously issuing buy signals, indicating a strong overall trend [1]. Signal Summary - The technical indicators for China Life Insurance have been summarized as a "strong buy," achieving a perfect score of 16, indicating multiple technical factors are resonating to support the stock's continued rise [3]. - Since May 20, the stock has consistently received "buy" to "strong buy" ratings, with clear market trends and active participation from major funds [3]. Derivative Products Performance - On May 26, when the underlying stock rose by 2.17%, related derivative products showed even more impressive gains, with Morgan Stanley's bull certificate (68142) leading with a 13% increase, followed by Citibank's call warrants (25657 and 25498) with increases of 12% and 11%, respectively [3]. Investment Products - For bullish strategies, Societe Generale's call warrant (15787) and Citibank's call warrant (15987) offer approximately 6.5 times leverage, with exercise prices around HKD 17.3 [6]. - Citibank's bull certificate (54112) provides a 6.1 times actual leverage with a recovery price of HKD 13.5, offering a higher safety margin for bullish investors [6]. - For bearish strategies, UBS's put warrant (14199) and Morgan Stanley's put warrant (13914) provide about 5.7 times leverage, both with exercise prices of HKD 13.88 [6]. - Citibank's bear certificate (57271) stands out with 8.3 times high leverage and the lowest premium, while UBS's bear certificate (57555) offers 6.7 times actual leverage [6]. Overall Market Outlook - China Life Insurance exhibits strong characteristics across various technical parameters, and if it can maintain the support level of HKD 15.50, it is expected to challenge the resistance levels of HKD 16.60 and HKD 17.00 [7]. - Despite some short-term indicators being at high levels, as long as trading volume and momentum remain healthy, there is still room for upward movement [7].

Core Viewpoint - China Life Insurance (02628) is experiencing a strong upward trend in its stock price, with a current price of 16.04 HKD and a daily increase of 1.78%, supported by multiple technical indicators signaling a "strong buy" despite being in an overbought state [1][4]. Technical Analysis - The technical indicators for China Life show a strong bullish pattern, with several moving averages indicating buy signals: MA10 at 15.79 HKD, MA30 at 14.72 HKD, and MA60 at 15.08 HKD, with the current price above these averages [1]. - The RSI index is at 66, indicating an overbought condition, while the William's indicator also signals a buy. Other indicators like ADX, psychological line, and momentum oscillators support a bullish outlook, although the overbought status suggests potential short-term pullback risks [1]. Support and Resistance Levels - The first short-term support level is at 15.4 HKD, with a second support level at 14.5 HKD if the price retraces. The first resistance level is at 16.5 HKD, and if this is breached, the stock could challenge the second resistance level at 17 HKD [4]. Product Performance - Recent performance of related derivative products has been strong, with products mentioned on May 22 showing a 6% increase within two days, highlighting the leverage effect of warrants and bull/bear certificates in a rising stock market [4]. Investment Products - For warrants, Citibank's call option (25498) has a high leverage with an exercise price of 16.9 HKD, suitable for investors expecting a breakout above 16.5 HKD. Morgan Stanley's call option (25657) offers a leverage of 11.4 times, appealing to aggressive investors [7]. - In terms of bear certificates, Citibank's bear certificate (57271) has a redemption price of 17.5 HKD and is suitable for short-term hedging, while UBS's bear certificate (57555) has a redemption price of 17.6 HKD, offering high leverage but with caution advised due to the resistance level at 16.5 HKD [7][8].